Work

Abstract CT107: A Phase Ib study to evaluate the MEK inhibitor cobimetinib in combination with the ERK1/2 inhibitor GDC-0994 in patients with advanced solid tumors

Year: 2017

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2017-ct107

Authors: Colin D. Weekes, Albert Lockhard, Patricia LoRusso, Elaine Murray, Erica Park, Michael Tagen, Lars Mueller, Hatem Dokainish, Geoffrey Shapiro, Howard Burris

Institutions: University of Colorado Denver, Washington University in St. Louis, Yale University, Dana-Farber Cancer Institute, Sarah Cannon

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2741913935

Cites:

Cited by: 11

Related to: 10